AtriCure Updates Revenue Guidance to $602M-$610M for 2026 and Raises Adjusted EBITDA Outlook
AtriCure reported Q2 revenue of $154 million, a 13% increase year-over-year. The company raised its adjusted EBITDA guidance to between $85 million and $89 million for the full fiscal year 2026.
Tickers: $ATRC
Topics: medical_devices revenue_growth